Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 6/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6677700 | 0.98 | L3MBTL1 (0.44) | L3MBTL1ALDH1A1KMT2ATDP1LMNA | |
| SCHEMBL1439757 | 0.85 | L3MBTL1 (0.47) | L3MBTL1ALDH1A1KMT2AMEN1GAA | |
| SCHEMBL1439290 | 0.84 | L3MBTL1 (0.46) | L3MBTL1ALDH1A1KMT2ATDP1LMNA | |
| SCHEMBL11125921 | 0.78 | L3MBTL1 (0.42) | L3MBTL1ALDH1A1KMT2ATDP1LMNA | |
| SCHEMBL1401342 | 0.78 | L3MBTL1 (0.42) | L3MBTL1ALDH1A1KMT2AMEN1GAA | |
| SCHEMBL19926076 | 0.77 | TSHR (0.41) | L3MBTL1ALDH1A1KMT2AMEN1TDP1 | |
| SCHEMBL17928311 | 0.75 | L3MBTL1 (0.45) | L3MBTL1ALDH1A1KMT2ATDP1LMNA | |
| SCHEMBL696377 | 0.75 | L3MBTL1 (0.43) | L3MBTL1ALDH1A1KMT2AMEN1GAA | |
| SCHEMBL1439129 | 0.75 | TDP1 (0.48) | L3MBTL1ALDH1A1KMT2AMEN1GAA | |
| SCHEMBL26311283 | 0.74 | L3MBTL1 (0.38) | L3MBTL1ALDH1A1KMT2AMEN1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1848426-A2 | TRICYCLIC CYTOPROTECTIVE COMPOUNDS | Hunter-Fleming Limited (GB) | 2007-10-31 | — | — | EP | disclosed |
| WO-2006082409-A2 | TRICYCLIC CYTOPROTECTIVE COMPOUNDS | HUNTER-FLEMING LIMITED (GB) | 2006-08-10 | — | — | WO | disclosed |
| EP-1471901-A1 | SPERMIDINE DERIVATIVES FOR THE TREATMENT OF CHRONIC NEURODEGENERATIVE DISEASES | UNIVERSITY OF SOUTHAMPTON (GB) | 2004-11-03 | — | — | EP | disclosed |
| WO-2003066037-A1 | SPERMIDINE DERIVATIVES FOR THE TREATMENT OF CHRONIC NEURODEGENERATIVE DISEASES | UNIVERSITY OF SOUTHAMPTON (GB) | 2003-08-14 | — | — | WO | disclosed |
| EP-1040096-A1 | NEUROPROTECTIVE AGENTS | THE UNIVERSITY OF SOUTHAMPTON (GB) | 2000-10-04 | — | — | EP | disclosed |
| WO-1999031049-A1 | NEUROPROTECTIVE AGENTS | UNIVERSITY OF SOUTHAMPTON (GB) | 1999-06-24 | — | — | WO | disclosed |